ProPharma is at the forefront of the life sciences industry and continues to innovate and elevate its position as the world’s largest RCO. Stay up to date on ProPharma’s latest news and most recent announcements.
December 15, 2020
DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...
September 22, 2020
Odyssey Investment Partners To Acquire ProPharma Group: Odyssey Investment Partners ("Odyssey") announced today that it has entered into an agreement to acquire ProPharma Group (or the "Company")...
September 22, 2020
Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on the healthcare sector, announced an agreement to sell ProPharma Group (the “Company”) to Odyssey...
March 11, 2019
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Southwood Research. Based in Buckinghamshire, United Kingdom, Southwood Research is a leading provider of...
January 28, 2019
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading provider of regulatory and...
August 30, 2018
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of SOLUTIONS in Health Inc., a Canada-based provider of medical information services to the pharmaceutical,...